InspireMD, Inc.
NSPR
$2.53
-$0.06-2.32%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -69.73% | -52.38% | -55.78% | -65.23% | -11.56% |
| Total Depreciation and Amortization | 22.95% | 20.69% | 13.79% | 25.45% | 12.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 54.49% | 42.86% | 161.90% | 602.57% | 256.01% |
| Change in Net Operating Assets | 347.06% | 95.25% | 33.15% | 42.86% | -111.06% |
| Cash from Operations | -61.60% | -40.98% | -30.95% | -4.82% | -30.74% |
| Capital Expenditure | -44.65% | -338.54% | -955.56% | -680.00% | -126.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4,759.66% | -184.90% | 122.27% | 12.03% | -95.58% |
| Cash from Investing | 22,994.44% | -192.77% | 120.48% | 8.27% | -100.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -57.66% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -52.43% | -- | -- |
| Foreign Exchange rate Adjustments | 207.14% | 144.90% | -900.00% | 81.82% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 173.78% | -647.82% | 159.61% | 37.87% | -701.58% |